Motrin is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Motrin was owned by Johnson & Johnson from 2006 to 2023.[2]
Motrin is an ibuprofen brand introduced in 1974 as a prescription anti-inflammatory and moved over the counter in 1984. It is sold mainly in North America, where it competes directly with Advil, and it transferred from Johnson & Johnson to Kenvue in the 2023 separation.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.